SpinalCyte, LLC Reports the Addition of Jeffrey Geesin, Ph.D. to Clinical Advisory Board
2/6/2013 7:21:39 AM
SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced the addition of Jeffrey Geesin, Ph.D. to its Clinical Advisory Board. Dr. Geesin, Former Director of Research & Development Advanced Technologies & Regenerative Medicine at Johnson & Johnson (JNJ), is one of the foremost authorities in the field of regenerative medicine.
comments powered by